Lab Updates

NGS for Diagnosis of Rett Syndrome and Related Disorders

Lab Updates
NGS for Diagnosis of Rett Syndrome and Related Disorders
Read Document

March 2024
Ampath | ampath.co.za

Overview

Rett syndrome is a spectrum of neurological disorders predominantly affecting females, ranging from:

  • Classic Rett syndrome
  • Atypical (variant) Rett syndrome
  • Milder learning disabilities

Classic Rett Syndrome:

  • Most often caused by pathogenic variants in the MECP2 gene (X chromosome)
  • Severe and progressive
  • Onset after apparently normal development (6–18 months)
  • Followed by:
    • Developmental plateau
    • Rapid skill regression
    • Stereotypic movements
    • Seizures
    • Acquired microcephaly
    • Ataxia
    • Dysautonomia

MECP2-Related Disorders in Males:

  • Range from:
    • Severe neonatal encephalopathy
    • Pyramidal signs
    • Parkinsonism
    • Macroorchidism (PPM-X syndrome)
    • Severe intellectual disability

Genetic Heterogeneity

While MECP2 variants account for the majority of classic Rett cases:

  • ~5% of classic Rett cases
  • ~25% of atypical Rett cases
    ...do not show MECP2 mutations.

Variants in other genes can mimic Rett syndrome clinically:

Other Relevant Genes:

  • CDKL5 – Early seizure onset, atypical Rett
  • FOXG1 – Congenital Rett presentation
  • MEF2C – Overlapping features with Rett
  • UBE3A – Accounts for ~11% of Angelman syndrome cases; features overlap with Rett

Diagnostic Testing at Ampath

Historically:

  • Targeted Sanger sequencing for MECP2 hotspots was used.

Now:

  • Next Generation Sequencing (NGS) on the Ion Torrent platform offers comprehensive coverage
  • Combined with MLPA (Multiplex Ligation-dependent Probe Amplification)
  • Detects both point mutations and deletions/duplications
  • Similar cost to older methods, but broader and more effective

Genes and Testing Methods Included

Ampath's NGS panel includes the following genes:

MECP2

  • Inheritance: X-linked dominant
  • Presentation: Classic Rett syndrome
  • Method: NGS (Exons 1–4) + MLPA (Exons 1–4)

CDKL5

  • Inheritance: X-linked dominant
  • Presentation: Atypical Rett
  • Method: NGS (Exons 2–18) + MLPA (Exons 3, 6, 9, 10)

FOXG1

  • Inheritance: Autosomal dominant
  • Presentation: Atypical Rett
  • Method: NGS (Exon 1)

MEF2C

  • Inheritance: Autosomal dominant
  • Presentation: Atypical Rett
  • Method: NGS (Exons 2–11)

UBE3A

  • Inheritance: Autosomal dominant
  • Presentation: Angelman syndrome
  • Method: NGS (Exons 3–13)

🔎 Note: UBE3A accounts for ~11% of Angelman syndrome.
First-line testing for Angelman syndrome should be requested separately using a methylation-sensitive MLPA technique.

Test Information

  • Mnemonic: RETT
  • Genes covered: MECP2, CDKL5, FOXG1, MEF2C, UBE3A
  • Specimen: Peripheral blood sample (EDTA)
  • Turnaround time: 6 weeks (from receipt at the National Reference Laboratory)
  • Cash price (2024): R5,224.00

📞 For more information:
Tel: 012 678 0645
Email: geneticsclinic@ampath.co.za